## Abstract Intravenous drug users constitute a group at risk for hepatitis C virus (HCV) infection. Today, no data are available on the molecular epidemiology of HCV in Bulgaria despite the fact that in recent years the incidence of acute hepatitis C infection among Bulgarian intravenous drug user
Molecular epidemiology of hepatitis C virus infection amongst intravenous drug users in rural communities
β Scribed by Ayaz Majid; Roger Holmes; Ulrich Desselberger; Peter Simmonds; Tom A. McKee
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 483 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
β¦ Synopsis
The prevalence of hepatitis C virus (HCV) infection amongst a group of intravenous drug users (IVDUs) resident in West Suffolk (East Anglia, England) was investigated and compared with the prevalence of infection with hepatitis B virus (HBV) and human immunodeficiency virus (HIV). In addition, both the level of HCV persistence, as defined by detection of viral RNA, and the HCV genotypes present in this population were determined. It was found that HCV antibodies were present in 59% of those tested; by comparison 22% had antibodies to HBV and 1% antibodies to HIV. HCV RNA was found in 44% of those with HCV antibody. HCV genotype 1 was the most prevalent within this population although both genotypes 2 and 3 were also represented.
π SIMILAR VOLUMES
## Abstract Hepatitis C virus subtype 3a (HCVβ3a) originates from Asia and has spread widely among injecting drug users as well as other patient groups in industrialized countries. HCV subtype 3a infection remains highly prevalent and frequently transmitted in the population of intravenous drug use
## Abstract The epidemiology and impact of occult HBV infection in intravenous drug users remain largely unknown. The aim of the study was to investigate the prevalence of occult HBV infection among intravenous drug users in Taiwan. Molecular assays were used to determine the level of serum HBV DNA
## Abstract The clinical relevance of hepatitis B virus (HBV) genotypes has been documented; however, the prevalence of mixed HBV genotype infections in atβrisk groups remains controversial. The HBV genotypes were determined in 325 HBVβinfected intravenous drug users (IVDU) who were at a greater ri
## Abstract To assess HCV genotype distribution and its determinants, 318 consecutive HCV RNA positive patients were examined. Subtype 1b infection was the most prevalent (35.5%), followed by subtype 1a (22%), 3a (21.4%) and 2 genotype (21.3%). Subtypes 1a, 1b and 3a had a comparable prevalence (30
## Abstract The aim of this study was to describe the distribution of hepatitis C genotypes among intravenous drug users in northβeastern Poland. The study group included intravenous drug users recruited at a drug treatment center and a clinic for HIVβinfected patients. HCV infection was confirmed